MS HB694

Amends Mississippi Code Section 73-21-127 to prohibit disclosure of prescription monitoring program (PMP) data in civil proceedings, including making data not subject to civil subpoena, discovery, or admissibility as evidence.

Maintains existing PMP requirements for mandatory reporting of controlled substance prescriptions (DEA Schedules II-V) by licensed pharmacies and practitioners, with exceptions for veterinarian prescriptions.

Permits authorized access to PMP data by pharmacists, prescribers, law enforcement, regulatory boards, Medicaid, grand juries, individuals requesting their own records, and other state PMP programs.

Grants the Director of the Mississippi Bureau of Narcotics access to the PMP database for investigating illegal acquisition, distribution, or dispensing of controlled substances.

Authorizes the State Board of Pharmacy to provide generic, nonidentifying statistical data for research and educational purposes.